A PHASE 3 RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY OF...

HemaSphere 2019 / 06 Vol. 3

A PHASE 3 RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY OF ISATUXIMAB, POMALIDOMIDE, AND LOW-DOSE DEXAMETHASONE VS POMALIDOMIDE AND LOW-DOSE DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

Attal, M., Richardson, P. G., Rajkumar, S. V., San-Miguel, J., Beksac, M., Spicka, I., Leleu, X., Schjesvold, F., Moreau, P., Dimopoulos, M. A., Huang, J.S.-Y., Minarik, J., Cavo, M., Prince, H. M., M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000561576.58696.ae
Date:
June, 2019
File:
PDF, 293 KB
2019
Conversion to is in progress
Conversion to is failed